热门资讯> 正文

Auria Pharmaceuticals股价因内部人士买入而上涨

2025-03-05 23:57

Aurinia制药(AUPH) 0
Time(TIME) 0

Aurinia Pharmaceuticals (NASDAQ:AUPH) shares rose about 7% in morning trade after its Director, Kevin Tang, disclosed purchase of company stocks.
Tang disclosed three transactions with the SEC, buying 399,280 shares for a price of $7.85 per share, 452,682 shares for a price of $8.01 per share and 748,038 shares for a price of $7.96 per share.
In total, the shares bought were of a value of approximately $12.7M.
Tang now holds about 10M shares of the company.

More on Aurinia Pharma

Aurinia Pharmaceuticals Inc. (AUPH) Q4 2024 Earnings Call Transcript
Aurinia Pharmaceuticals: There's Still Time For Sales Growth
Aurinia: My 2024 Sell Call Was Wrong - So I'm Upgrading To 'Hold' In 2025
Aurinia Pharma reports mixed Q4 results; initiates FY25 outlook
Seeking Alpha’s Quant Rating on Aurinia Pharma

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。